Targeted therapies: Remembrance of things past - discontinuation of second-generation TKI therapy for CML. [electronic resource]
Producer: 20180312Description: 201-202 p. digitalISSN:- 1759-4782
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.